Stewardship Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$214K Sell
3,391
-87
-3% -$5.41K 0.07% 61
2020
Q4
$216K Hold
3,478
0.08% 58
2020
Q3
$210K Hold
3,478
0.09% 53
2020
Q2
$205K Buy
+3,478
New +$208K 0.09% 52
2020
Q1
Sell
-3,859
Closed -$248K 66
2019
Q4
$248K Buy
+3,859
New +$221K 0.09% 50

Other funds holding BMY

Stewardship Financial Advisors's BMY Position: Q1 2021 in Review

Stewardship Financial Advisors reduced its Bristol-Myers Squibb (BMY) stake by 2.5% in Q1 2021, selling an estimated $5.41K and leaving 3,391 shares worth $214K. The position accounts for 0.07% of the portfolio, ranked #61.

Stewardship Financial Advisors first reported a position in BMY in Q4 2019 and has held it in 5 quarters since. The position peaked at $248K in Q4 2019. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

  • Stewardship Financial Advisors held 3,391 shares of Bristol-Myers Squibb worth $214K as of Q1 2021.
  • Stewardship Financial Advisors sold 87 Bristol-Myers Squibb shares in Q1 2021, an estimated $5.41K.
  • Bristol-Myers Squibb made up 0.07% of Stewardship Financial Advisors's portfolio in Q1 2021, its #61 holding.
  • Stewardship Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 5 quarters since.
  • Stewardship Financial Advisors's Bristol-Myers Squibb position peaked at $248K in Q4 2019.
  • 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Stewardship Financial Advisors's 13F filing for Q1 2021, filed 16 Apr 2021.